Jabil Acquires Pharmaceutics International (Pii)
February 6, 2025
Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.
- Buyers
- Jabil Inc.
- Targets
- Pharmaceutics International (Pii)
- Sellers
- Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital, Pharmascience Inc.
- Industry
- Pharmaceuticals
- Location
- Maryland, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.